Benjamin Lyons

1.2k total citations
9 papers, 868 citations indexed

About

Benjamin Lyons is a scholar working on Oncology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin Lyons has authored 9 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Psychiatry and Mental health and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin Lyons's work include Peptidase Inhibition and Analysis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Benjamin Lyons is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Dementia and Cognitive Impairment Research (2 papers). Benjamin Lyons collaborates with scholars based in United States, United Kingdom and Spain. Benjamin Lyons's co-authors include Eduard Vieta, Michelle Kramer, Sumant Khanna, Mariëlle Eerdekens, Fred Grossman, F. Stephen Hodi, Mizuki Nishino, Ina Rhee, Kimmie Ng and David C. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The British Journal of Psychiatry.

In The Last Decade

Benjamin Lyons

9 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Lyons United States	9	468	209	199	182	146	9	868
Donata Villari Italy	19	180 0.4×	62 0.3×	116 0.6×	331 1.8×	294 2.0×	65	1.2k
Tobias Höller Germany	22	319 0.7×	117 0.6×	36 0.2×	154 0.8×	392 2.7×	39	1.2k
Franco Morelli Italy	15	283 0.6×	44 0.2×	71 0.4×	428 2.4×	256 1.8×	59	915
M Bolla France	9	142 0.3×	92 0.4×	58 0.3×	435 2.4×	81 0.6×	26	765
J M Birch United Kingdom	16	256 0.5×	53 0.3×	59 0.3×	146 0.8×	234 1.6×	19	980
Michael Hardin United States	9	347 0.7×	69 0.3×	68 0.3×	396 2.2×	574 3.9×	11	1.1k
Hong-Jun Song China	20	231 0.5×	203 1.0×	20 0.1×	233 1.3×	209 1.4×	57	1.1k
Dimosthenis Chrysikos Greece	18	457 1.0×	67 0.3×	35 0.2×	254 1.4×	253 1.7×	119	1.2k
Susan A. Melin United States	17	375 0.8×	280 1.3×	13 0.1×	258 1.4×	105 0.7×	35	1.1k
Katarzyna Ziemnicka Poland	20	168 0.4×	72 0.3×	34 0.2×	51 0.3×	218 1.5×	89	972

Countries citing papers authored by Benjamin Lyons

Since Specialization

Citations

This map shows the geographic impact of Benjamin Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lyons more than expected).

Fields of papers citing papers by Benjamin Lyons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lyons. The network helps show where Benjamin Lyons may publish in the future.

Co-authorship network of co-authors of Benjamin Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Lyons. A scholar is included among the top collaborators of Benjamin Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Lyons. Benjamin Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hodi, F. Stephen, Marcus Ballinger, Benjamin Lyons, et al.. (2018). Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy. Journal of Clinical Oncology. 36(9). 850–858. 242 indexed citations

Sofen, Howard, Kenneth G. Gross, Leonard H. Goldberg, et al.. (2015). A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. Journal of the American Academy of Dermatology. 73(1). 99–105.e1. 56 indexed citations

Herbst, Roy S., Angela M. Davies, Ronald B. Natale, et al.. (2007). Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non–Small Cell Lung Cancer. Clinical Cancer Research. 13(20). 6175–6181. 79 indexed citations

Agus, David B., Christopher J. Sweeney, Michael J. Morris, et al.. (2007). Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer After Progression From Taxane-Based Therapy. Journal of Clinical Oncology. 25(6). 675–681. 75 indexed citations

Tabet, Naji, et al.. (2006). Behavioural and Psychological Symptoms of Alzheimer Type Dementia Are Not Correlated with Plasma Homocysteine Concentration. Dementia and Geriatric Cognitive Disorders. 22(5-6). 432–438. 14 indexed citations

Gordon, Michael S., Daniela Matei, Carol Aghajanian, et al.. (2006). Clinical Activity of Pertuzumab (rhuMAb 2C4), a HER Dimerization Inhibitor, in Advanced Ovarian Cancer: Potential Predictive Relationship With Tumor HER2 Activation Status. Journal of Clinical Oncology. 24(26). 4324–4332. 187 indexed citations

Khanna, Sumant, Eduard Vieta, Benjamin Lyons, et al.. (2005). Risperidone in the treatment of acute mania. The British Journal of Psychiatry. 187(3). 229–234. 131 indexed citations

Deyn, Peter Paul De, Ira R. Katz, Henry Brodaty, et al.. (2005). Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone. Clinical Neurology and Neurosurgery. 107(6). 497–508. 72 indexed citations

Khanna, S., et al.. (2003). P.2.080 Risperidone in the treatment of acute bipolar mania: A double-blind, placebo-controlled study of 290 patients. European Neuropsychopharmacology. 13. S314–S315. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact